Supplemental Disclosure of Cash Flow Information |
Note 14 – Supplemental Disclosure
of Cash Flow Information
|
|
Nine Months Ended September 30, |
|
|
|
2019 |
|
|
2018 |
|
Cash paid for interest |
|
$ |
- |
|
|
$ |
303,208 |
|
Cash paid for income taxes |
|
|
45,000 |
|
|
|
20,000 |
|
|
|
|
|
|
|
|
|
|
Acquisitions of Hospitals and Medical Center: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
- |
|
|
$ |
375 |
|
Inventory |
|
|
317,427 |
|
|
|
450,682 |
|
Prepaid expenses and other current assets |
|
|
- |
|
|
|
310,385 |
|
Property and equipment |
|
|
500,000 |
|
|
|
7,129,484 |
|
Intangible assets |
|
|
250,000 |
|
|
|
504,806 |
|
Accrued expenses |
|
|
158,890 |
|
|
|
193,966 |
|
|
|
|
|
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Exchange of Series I-2 Preferred Stock for common stock |
|
$ |
1,143,974 |
|
|
$ |
633,101 |
|
Cashless exercise of warrants |
|
|
11,961 |
|
|
|
4,619,150 |
|
Debentures converted into common stock |
|
|
- |
|
|
|
8,085,342 |
|
Common stock issued in cashless exercise of warrants |
|
|
11,961 |
|
|
|
- |
|
Exchange of debentures into Series I-2 Preferred Stock |
|
|
- |
|
|
|
1,420 |
|
Conversions of Series H Preferred Stock into common stock |
|
|
- |
|
|
|
50,000 |
|
Original issue discount of debentures and notes payable |
|
|
400,000 |
|
|
|
1,920,000 |
|
Deemed dividend for trigger of down round provision features |
|
|
123,861,587 |
|
|
|
17,942,578 |
|
Issuance of Series J Preferred Stock in settlement of note payable to related party |
|
|
- |
|
|
|
250,000 |
|
|